Patwardhan Manjul MD Cupertino, CA - 95014

Patwardhan Manjul MD is categorized under Family Practice Doctors in Cupertino, CA and active since 2005.

Patwardhan Manjul MD was established in 2005, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Manjul Patwardhan at the company’s single location by writing to 10353 Torre Avenue # A, Cupertino, California CA 95014 or by phoning (408) 725-1777. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Patwardhan Manjul MD
Contact Person: Manjul Patwardhan
Address: 10353 Torre Avenue # A, Cupertino, California 95014
Phone Number: (408) 725-1777
Website Address: myfamilyphysician.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Family Practice Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Patwardhan Manjul MD was started in 2005 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Manjul Patwardhan for inquiries that concern Patwardhan Manjul MD by calling the company number (408) 725-1777, as your correspondence is most welcome. Additionally, the physical location of the single location of Patwardhan Manjul MD can be found at the coordinates 37.31733,-122.0293 as well as the street address 10353 Torre Avenue # A in Cupertino, California 95014.

For its online presence, you may visit Patwardhan Manjul MD’s website at myfamilyphysician.com and engage with its social media outlets through on Twitter and on Facebook.